StockData

Carlisle Companies vs Advanced Drainage Systems

CSL and WMS side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CSL and WMS compare

Carlisle Companies is the larger company, worth 1.5 times as much as Advanced Drainage Systems ($14.9B against $10.2B).

On earnings, Carlisle Companies is cheaper: it trades at 21.6× trailing earnings, against 23.4× for Advanced Drainage Systems.

Advanced Drainage Systems grew revenue faster over the last twelve months (10.4% versus 1.9% for Carlisle Companies).

Carlisle Companies keeps more of each dollar of sales as profit, with a net margin of 14.2% compared with 14.0% at Advanced Drainage Systems.

Both pay dividends: Carlisle Companies yields 1.2% and Advanced Drainage Systems 0.56%.

Advanced Drainage Systems scores higher on the StockData Score (17 against 15 for Carlisle Companies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCSLWMS
Size and price
Market cap$14.9B$10.2B
Share price$376.31$135.43
Change, 1 year13.6%−3.1%
Change, 5 years61.3%9.4%
Beta (5Y)0.921.43
Employees5,9004,950
StockData Score
Total score1517 (better)
Valuation score22
Growth score03 (better)
Performance score55
Health score44
Dividend score4 (better)3
Valuation
P/E21.6× (better)23.4×
P/S2.9× (better)3.2×
P/B9.2×5.7× (better)
EV/EBITDA14.1×13.0× (better)
P/FCF17.2× (better)18.6×
FCF yield5.8% (better)5.4%
Fair value$355.93$132.53
Margin of safety−5.7%−2.2% (better)
Growth
Revenue growth (TTM)1.9%10.4% (better)
Revenue growth, 5Y average4.8%9.0% (better)
Net income growth (TTM)−10.1%4.2% (better)
EPS growth (TTM)−2.7%4.5% (better)
EPS growth, 5Y average24.2% (better)16.0%
Profitability
Gross margin35.3%38.6% (better)
Operating margin19.9%20.7% (better)
Net margin14.2% (better)14.0%
FCF margin17.0%17.1% (better)
Return on equity38.8% (better)26.1%
Return on invested capital20.2% (better)18.4%
Financial health
Debt / equity1.790.90 (better)
Net debt / EBITDA1.831.62 (better)
Interest coverage9.7×–
Current ratio2.60 (better)2.12
Altman Z-score5.28 (better)4.34
Piotroski F-score6 (better)4
Dividends and buybacks
Dividend yield1.2% (better)0.56%
Payout ratio25.2%12.7%
Years of dividend growth16 (better)5
Dividend growth, 5Y average15.4% (better)14.9%
Buyback yield7.4% (better)3.2%
Shareholder yield8.6% (better)3.7%
Ownership
Held by institutions104%92.4%
Held by insiders1.4%1.2%
Insider net buying, 12 months−$28.2M−$14.8M (better)
Superinvestors holding1–
Short interest, % of float5.1%4.0%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.